Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases

Journal of Hepatology

Volumn 25, Issue 6, 1996, Pages 859-866

  Strassburg, Christian P ^a   Alex, Britta ^a   Zindy, Fréderique ^b   Gerken, Guido ^c   Lüttig, Birgit ^a   Meyer Zum Büschenfelde, Karl Hermann ^c   Bréchot, Christian ^b   Manns, Michael P ^a,d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b INSERM   (France)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Abt Gastroenterologie Hepatologie   (Germany)

Author keywords

Antinuclear antibodies; Autoimmune hepatitis; Autoimmune liver disease; Baculovirus expression; Cell regulation; Cell transformation; Cyclin A; Epitope; Primary biliary cirrhosis; Rheumatic disease

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLIN A;

ARTICLE; AUTOIMMUNE HEPATITIS; BACULOVIRUS; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RHEUMATIC DISEASE;

EID: 0030445037     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80290-X     Document Type: Article

References (49)

1. 1. Nakamura RM, Tan EM. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases. Clin Lab Med 1992; 12: 1.
2. 2. Waldenström J. Leber, Blutproteine und Nahrungseiweiß. Dtsch Z Verdauungs -und Stoffwechselkrankheiten 1950; 15, 113-21.
3. 3. Mackay IR, Taft LI, Cowling DC Lupoid hepatitis. Lancet 1956; ii: 1323-6.
4. 4. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
5. 5. Szostecki C, Guldner HH, Netter HJ, Will H. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol 1990; 145: 4338-47.
6. 6. Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 1994; 106: 193-9.
7. 7. Kloppel G, Seifert G, Lindner H, Dammermann R, Sack HJ, Berg PA Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis Virchows Arch 1977; 373, 143-60.
8. 8. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993; 18: 10-5.
9. 9. Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, Palmer JM, Heathcote EJ. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 1994; 35: 260-5.
10. 10. Tan EM. Antinuclear antibodies. Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-151.
11. 11. Manns MP, Griffin KJ, Sullivan KF, Johnson EF LKM-1 autoantibodies recognize a short linear sequence in P450II D6, a cytochrome P-450 monooxygenase. J Clin Invest 1991; 88: 1370-8.
12. 12. Philipp T, Durazzo M, Trautwein C, Alex B, Straub P, Lamb JG, Johnson EF, Tukey RH, Manns MP Recognition of uridine diphosphate glucuronosyl transferase by LKM-3 antibodies in chronic hepatitis D. Lancet 1994; 344: 578-81.
13. 13. Pines J. Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem Sci 1993; 18: 195-7.
14. 14. Hunter P, Pines J. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79, 573-82.
15. 15. Nurse P. Ordering S phase and M phase in the cell cycle. Cell 1994; 79: 547-50.
16. 16. Swenson KI, Farrell KM, Ruderman JV. The clam embryo protein cyclin A induces entry into M phase and the resumption of meiosis in Xenopus oocytes. Cell 1986; 47: 861-70.
17. 17. Draetta G. Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation. TIBS 1990; 15: 378-83.
18. 18. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-65.
19. 19. Nurse P. Universal control mechanisms regulating onset of M phase. Nature 1990; 344: 503-7.
20. 20. Zindy F, Lamas E, Chenivesse X, Sobczak J, Wang J, Fesquet D, Henglein B, Bréchot C. Cyclin A is required in S phase in normal epithelial cells. Biochem Biophys Res Commun 1992; 182: 1144-54.
21. 21. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J 1992; 11: 961-71.
22. 22. Rosenberg AR, Zindy F, LeDeist F, Mouly H, Métézeau P, Bréchot C, Lamas E Overexpression of human cyclin A advances entry into S phase. Oncogene 1995; 10: 1501-9.
23. 23. Henglein B, Chenivesse X, Wang J, Eick D, Bréchot C. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci USA 1994; 91: 5490-4.
24. 24. Evans T, Rosenthal ET, Youngblom J, Distel D, Hunt T. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 1983; 33: 389-96.
25. 25. Pines J, Hunter T. Human cyclin A is adenovirus E1-A associated protein p60 and behaves differently from cyclin B. Nature 1990; 346: 760-3.
26. 26. Tsai LH, Harlow E, Meyerson M. Isolation of the human cdk2 gene that encodes the cyclin A and adenovirus E1A-associated p33 kinase. Nature 1991; 353: 174-7.
27. 27. Walker DH, Maller JH. Role for cyclin A in the dependence of mitosis on completion of DNA replication. Nature 1991; 354: 314-7.
28. 28. Sobczak-Thépot J, Harper F, Florentin Y, Zindy F, Bréchot C, Puvion E. Localization of cyclin A at the site of DNA replication. Exp Cell Res 1993; 206: 43-8.
29. 29. Cardoso MC, Leonhardt H, Nadal-Ginard B. Reversal of terminal differentiation and control of DNA replication: cyclin A and cdk2 specifically localize at subnuclear sites of DNA replication. Cell 1993; 74: 979-92.
30. 30. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chitenden T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 1992; 68: 157-66.
31. 31. Devoto SH, Mudryi M, Pines J, Hunter T, Nevins JR. A cyclin A-protein kinase complex possesses sequence specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell 1992; 68: 167-76.
32. 32. Mudryi M, Hiebert SW, Nevins JR. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J 1990; 7: 2179-84.
33. 33. Dynlacht BD, Flores O, Lees JA, Harlow E. Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes Dev 1994; 8: 1772-86.
34. 34. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG, Livingstone DM. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 1994; 78: 161-72.
35. 35. Nevins J. Cell cycle targets of the DNA tumor viruses. Curr Opin Genet Dev 1994; 4: 130-4.
36. 36. Wang J, Chenivesse X, Henglein B, Bréchot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 1990; 343: 555-7.
37. 37. Guadagno TM, Ohtsubo M, Roberts JM, Assoian RK. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 1993; 262: 1572-5.
38. 38. Meikrantz W, Gisselbrecht S, Tam SW, Schlegel R Activation of cyclin A-dependent kinases during apoptosis. Proc Natl Acad Sci 1994; 91: 3754-8.
39. 39. Fisher DE Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78: 539-42.
40. 40. Manns M, Gerken G, Kyriatsoulis A, Trautwein C, Reske K, Meyer zum Büschenfelde K-H. Two different subtypes of antimitochondrial antibodies are associated with primary biliary cirrhosis: identification and characterization by radioimmunoassay and immunoblotting. Hepatology 1987; 5: 893-9
41. 41. Mackay IR, Gershwin ME. Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens. Springer Semin Immunopathol 1990; 12: 101-9.
42. 42. Bassendine MF, Yeaman SJ. Primary biliary cirrhosis: nature of autoantigens. Springer Semin Immunopathol 1990; 12: 73-83.
43. 43. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
44. 44. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde K-H Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987; i: 292-4.
45. 45. Strassburg CP, Kasai Y, Seng BA, Miniou P, Zaloudik J, Herlyn D, Koprowski H, Linnenbach AJ. Baculovirus recombinant expressing a secreted form of a transmembrane carcinoma-associated antigen. Cancer Res 1992; 52: 815-21.
46. 46. Strassburg CP, Manns M. Autoimmune hepatitis versus viral hepatitis C. Liver 1995; 15: 225-32.
47. 47. Beaune P, Pessayre D, Dansette P, Mansuy D, Manns M. Autoantibodies against cytochromes P450: role in human diseases. Adv Pharmacol 1994; 30: 199-245.
48. 48. Strassburg CP, Obermayer-Straub P, Alex B, Durazzo M, Rizzetto M, Tukey RH, Manus MP. LKM-3 autoantibodies against UDP-glucuronosyltransferases differ in viral hepatitis and autoimmune hepatitis. Gastroenterology 1996; in press.
49. 49. Luckow VA, Summers MD. Trends in the development of baculovirus expression vectors. Biotechnology 1988; 6: 47-55.